Drugs / Meridol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT06563518 | Jan → Jul 2022 | gingivitis | Colgate Palmolive | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT07842978 Comparator | Oct 2026 → Apr 2027 expected | gingivitis | Colgate Palmolive | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Meridol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07842978 ↗ |